COR - Cencora, Inc.


260.93
1.230   0.471%

Share volume: 1,795,184
Last Updated: 05-12-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries: 0.04%

PREVIOUS CLOSE
CHG
CHG%

$259.70
1.23
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
54%
Profitability 45%
Dept financing 37%
Liquidity 44%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
-0.06%
1 Month
-18.23%
3 Months
-27.69%
6 Months
-28.60%
1 Year
-6.48%
2 Year
4.10%
Key data
Stock price
$260.93
P/E Ratio 
23.98
DAY RANGE
$259.07 - $264.92
EPS 
$13.12
52 WEEK RANGE
$244.82 - $377.54
52 WEEK CHANGE
-$6.53
MARKET CAP 
61.110 B
YIELD 
0.73%
SHARES OUTSTANDING 
194.561 M
DIVIDEND
$0.60
EX-DIVIDEND DATE
05-15-2026
NEXT EARNINGS DATE
07-30-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$3,103,596
AVERAGE 30 VOLUME 
$1,962,897
Company detail
CEO: Steven H. Collis
Region: US
Website: www.cencora.com
Employees: 42,000
IPO year: 1995
Issue type:
Market: NYSE
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

Cencora, Inc. sources and distributes pharmaceutical products. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Recent news